JPRN-C000000115CompletedPhase 1
A phase I/II study of weekly intraperitoneal paclitaxel +monthly intravenous carboplatin for mullerian carcinoma (ovarian, tubal, and peritoneal carcinoma) - Weekly IP PAC+CBDCA for mullerian carcinoma
atinonal Hospital Organization Kobe Medical Center0 sites12 target enrollmentStarted: September 9, 2005Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 12
Study Overview
Brief Summary
By now 12 patients were recruited, and all patients were completed. As for pharmacokinetics and adverse events the results were reported at 2004 ASCO procedings. At ECCO 12 meeting the presentation was made according to the results except for survival. The survivals and outcome would be reported soon.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 15years-old to 75years-old (—)
- Sex
- Female
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1)Whom not to be suitable for eligibility criateria (2)Known severe hypersensitivityor having past illness of hypersensitivity to any drug (3)pregnant,milk-feeding woman or who is expected to be pregnant (4)Who have too much pleural effusion or pericardial effsion. (5)Known hypersensitivity to these drugs(paclitaxel, and/or carboplatin) or to agent containing polyoxiethilene cremophol such as cyclosporine injection
Investigators
Similar Trials
Recruiting
Phase 1
A phase 1 clinical trial of intraperitoneal administration of iCAR-ILC/N101 for ovarian clear cell carcinomaPatients with GPC3-expressing advanced ovarian clear cell carcinoma with peritoneal disseminationovarian clear cell carcinomaJPRN-jRCT2033200431Harano Kenichi18
Unknown
Phase 2
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.Hepatitis BNCT00044135Triangle Pharmaceuticals30
Completed
Phase 1
Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.Ovarian NeoplasmsFallopian Tube NeoplasmsPeritoneal NeoplasmsNCT02903771Kazia Therapeutics Limited28
Completed
Not Applicable
A study to evaluate the efficacy of intraperitoneal paclitaxel in combination with systemic S-1 and cisplatin in advanced gastric cancer with peritoneal dissemination and ascites.NeoplasmsKCT0003607Yonsei University Health System, Severance Hospital45
Completed
Phase 2
Safety and Efficacy of Dr. Tagliaferri's Menopause FormulaHot FlashesNCT01957306Herba Buena, Inc30